These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 25752620

  • 1. Cyanidin-3-O-Glucoside Ameliorates Lipopolysaccharide-Induced Injury Both In Vivo and In Vitro Suppression of NF-κB and MAPK Pathways.
    Ma MM, Li Y, Liu XY, Zhu WW, Ren X, Kong GQ, Huang X, Wang LP, Luo LQ, Wang XZ.
    Inflammation; 2015 Aug; 38(4):1669-82. PubMed ID: 25752620
    [Abstract] [Full Text] [Related]

  • 2. Cyanidin-3-O-β-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts.
    Fu Y, Zhou E, Wei Z, Wang W, Wang T, Yang Z, Zhang N.
    Biochem Pharmacol; 2014 Jul 15; 90(2):126-34. PubMed ID: 24841888
    [Abstract] [Full Text] [Related]

  • 3. Cyanidin-3-glucoside inhibits inflammatory activities in human fibroblast-like synoviocytes and in mice with collagen-induced arthritis.
    Sun Y, Li L.
    Clin Exp Pharmacol Physiol; 2018 Oct 15; 45(10):1038-1045. PubMed ID: 29779214
    [Abstract] [Full Text] [Related]

  • 4. Cyanidin-3-O-glucoside attenuates acute lung injury in sepsis rats.
    Yan X, Wu L, Li B, Meng X, Dai H, Zheng Y, Fu J.
    J Surg Res; 2015 Dec 15; 199(2):592-600. PubMed ID: 26152793
    [Abstract] [Full Text] [Related]

  • 5. The protective effect of lidocaine on lipopolysaccharide-induced acute lung injury in rats through NF-κB and p38 MAPK signaling pathway and excessive inflammatory responses.
    Chen LJ, Ding YB, Ma PL, Jiang SH, Li KZ, Li AZ, Li MC, Shi CX, Du J, Zhou HD.
    Eur Rev Med Pharmacol Sci; 2018 Apr 15; 22(7):2099-2108. PubMed ID: 29687869
    [Abstract] [Full Text] [Related]

  • 6. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
    Chen C, Li L, Liu X, Zhang D, Liu Y, Li Y.
    J Ethnopharmacol; 2023 Jan 10; 300():115725. PubMed ID: 36115602
    [Abstract] [Full Text] [Related]

  • 7. The natural product bergenin ameliorates lipopolysaccharide-induced acute lung injury by inhibiting NF-kappaB activition.
    Yang S, Yu Z, Wang L, Yuan T, Wang X, Zhang X, Wang J, Lv Y, Du G.
    J Ethnopharmacol; 2017 Mar 22; 200():147-155. PubMed ID: 28192201
    [Abstract] [Full Text] [Related]

  • 8. Schisantherin A protects lipopolysaccharide-induced acute respiratory distress syndrome in mice through inhibiting NF-κB and MAPKs signaling pathways.
    Zhou E, Li Y, Wei Z, Fu Y, Lei H, Zhang N, Yang Z, Xie G.
    Int Immunopharmacol; 2014 Sep 22; 22(1):133-40. PubMed ID: 24975658
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
    Liu F, Sun GQ, Gao HY, Li RS, Soromou LW, Chen N, Deng YH, Feng HH.
    J Surg Res; 2013 Nov 22; 185(1):300-9. PubMed ID: 23816246
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.